Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2) and (#3 or #4)
Latest & greatest articles for breast cancer screening
The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on breast cancer screening or other clinical topics then use Trip today.
This page lists the very latest high quality evidence on breast cancer screening and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.
What is Trip?
Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.
Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.
As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.
For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via email@example.com
Mammographic screening and mortality from breastcancer: the MalmÃ¶ mammographic screening trial. To determine whether mortality from breastcancer could be reduced by repeated mammographic screening.Birth year cohorts of city population separately randomised into study and control groups.Screening clinic outside main hospital.Women aged over 45; 21,088 invited for screening and 21,195 in control group.Women in the study group were invited to attend for mammographic screening at intervals of 18 (...) -24 months. Five rounds of screening were completed. Breastcancer was treated according to stage at diagnosis.Mortality from breast cancer.All women were followed up and classed at end point as alive without breastcancer, alive with breastcancer, dead from breastcancer, or dead from other causes. Cause of death was taken from national mortality registry and for patients with breastcancer was validated independently. Mean follow up was 8.8 years. Altogether 588 cases of breastcancer were
Survival in breastcancer diagnosed between mammographic screening examinations. In women drawn from a randomised, population-based trial of mammography screening for breastcancer the overall actuarial survival and disease-free survival for up to 7 years of observation were similar in 94 patients with interval cancers and 178 control patients with cancer diagnosed independent of screening. The similarity was confirmed by multiple regression analysis. These results contradict the hypothesis (...) that a high growth rate of the primary tumour is associated with a greater metastatic potential and do not support the concept that patients with interval cancers should receive more aggressive local or systemic treatment.
Reduction in mortality from breastcancer after mass screening with mammography. Randomised trial from the BreastCancerScreening Working Group of the Swedish National Board of Health and Welfare. A randomised controlled trial to investigate the efficacy of mass screening with single-view mammography in reducing mortality from breastcancer was started in Sweden in 1977. 162 981 women aged 40 years or more and living in the counties of Kopparberg and Ostergötland were enrolled in the study (...) and divided at random into 2 groups. Each woman in the study group was offered screening every 2 or 3 years depending on age. Women in the control group were not offered screening. This report is confined to the 134 867 women aged 40-74 years at date of entry. The results to the end of 1984 show a 31% reduction in mortality from breastcancer and a 25% reduction in the rate of stage II or more advanced breastcancers in the group invited to screening. 7 years after the start of the study the excess
Reduction of breastcancer mortality through mass screening with modern mammography. First results of the Nijmegen project, 1975-1981. Since 1975 four rounds of screening with modern mammography for breastcancer have been carried out among 30 000 Nijmegen women born before 1940. The results up to the end of 1981 shows that the odds ratio of screened vs unscreened subjects among women who died from breastcancer compared with women who did not, was 0.48 (95% confidence interval 0.23-1.00
details Gravelle H S, Simpson P R, Chamberlain J. Breastcancerscreening and health service costs. Journal of Health Economics 1982; 1(2): 185-207 PubMedID Indexing Status Subject indexing assigned by NLM MeSH Adult; BreastNeoplasms /epidemiology /prevention & Costs and Cost Analysis; Female; Great Britain; Humans; Mammography /economics; Mass Screening /economics; Middle Aged; State Medicine /economics; control AccessionNumber 21995005276 Date bibliographic record published 06/08/1996 Date abstract (...) Breastcancerscreening and health service costs Breastcancerscreening and health service costs Breastcancerscreening and health service costs Gravelle H S, Simpson P R, Chamberlain J Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Type
Evaluation of periodic breastcancerscreening with mammography. Methodology and early observations. 5951878 1966 04 09 2016 10 17 0098-7484 195 9 1966 Feb 28 JAMA JAMA Evaluation of periodic breastcancerscreening with mammography. Methodology and early observations. 731-8 Shapiro S S Strax P P Venet L L eng Clinical Trial Journal Article Randomized Controlled Trial United States JAMA 7501160 0098-7484 AIM IM Adult Biopsy BreastNeoplasms diagnosis epidemiology Connecticut Female Follow-Up (...) Studies Humans Mammography Mass Screening Mastectomy Middle Aged Mortality New York Prognosis 1966 2 28 1966 2 28 0 1 1966 2 28 0 0 ppublish 5951878